Annual SGA
$29.91 M
-$1.84 M-5.80%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual SGA is $29.91 million, with the most recent change of -$1.84 million (-5.80%) on December 31, 2022.
- During the last 3 years, EVLO annual SGA has risen by +$6.68 million (+28.77%).
- EVLO annual SGA is now -5.80% below its all-time high of $31.75 million, reached on December 31, 2021.
Performance
EVLO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.89 M
-$1.02 M-20.83%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly SGA is $3.89 million, with the most recent change of -$1.02 million (-20.83%) on September 30, 2023.
- Over the past year, EVLO quarterly SGA has dropped by -$3.23 million (-45.40%).
- EVLO quarterly SGA is now -61.52% below its all-time high of $10.11 million, reached on September 30, 2021.
Performance
EVLO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.25 B
-$82.35 M-3.80%
September 30, 2023
Summary
- As of February 8, 2025, EVLO TTM SGA is -$2.25 billion, with the most recent change of -$82.35 million (-3.80%) on September 30, 2023.
- Over the past year, EVLO TTM SGA has dropped by -$2.28 billion (-6791.52%).
- EVLO TTM SGA is now -3884.12% below its all-time high of -$56.41 million.
Performance
EVLO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
EVLO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.8% | -45.4% | -6791.5% |
| 3 y3 years | +28.8% | -26.2% | -10000.0% |
| 5 y5 years | +294.9% | -25.6% | -9776.6% |
EVLO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | at low | -58.7% | at low | -52.5% | at low |
| 5 y | 5-year | -5.8% | +34.3% | -61.5% | at low | -238.8% | at low |
| alltime | all time | -5.8% | +668.8% | -61.5% | +185.7% | -3884.1% | at low |
Evelo Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $3.89 M(-20.8%) | $20.85 M(-13.4%) |
| Jun 2023 | - | $4.92 M(-30.2%) | $24.09 M(-12.5%) |
| Mar 2023 | - | $7.04 M(+40.8%) | $27.54 M(-7.9%) |
| Dec 2022 | $29.91 M(-5.8%) | $5.00 M(-29.8%) | $29.91 M(-10.9%) |
| Sep 2022 | - | $7.13 M(-14.8%) | $33.59 M(-8.2%) |
| Jun 2022 | - | $8.37 M(-11.2%) | $36.57 M(+3.9%) |
| Mar 2022 | - | $9.42 M(+8.5%) | $35.21 M(+10.9%) |
| Dec 2021 | $31.75 M(+42.6%) | $8.68 M(-14.2%) | $31.75 M(+8.9%) |
| Sep 2021 | - | $10.11 M(+44.4%) | $29.16 M(+19.9%) |
| Jun 2021 | - | $7.00 M(+17.4%) | $24.32 M(+8.6%) |
| Mar 2021 | - | $5.96 M(-2.0%) | $22.39 M(+0.5%) |
| Dec 2020 | $22.27 M | $6.08 M(+15.4%) | $22.27 M(-0.9%) |
| Sep 2020 | - | $5.27 M(+4.0%) | $22.48 M(-2.7%) |
| Jun 2020 | - | $5.07 M(-13.2%) | $23.09 M(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $5.84 M(-7.2%) | $23.94 M(+3.1%) |
| Dec 2019 | $23.23 M(+27.5%) | $6.29 M(+6.9%) | $23.23 M(+7.6%) |
| Sep 2019 | - | $5.89 M(-0.6%) | $21.58 M(+3.1%) |
| Jun 2019 | - | $5.92 M(+15.6%) | $20.93 M(+4.3%) |
| Mar 2019 | - | $5.12 M(+10.2%) | $20.06 M(+10.1%) |
| Dec 2018 | $18.22 M(+140.5%) | $4.65 M(-11.1%) | $18.22 M(+17.1%) |
| Sep 2018 | - | $5.23 M(+3.4%) | $15.56 M(+19.5%) |
| Jun 2018 | - | $5.06 M(+54.1%) | $13.02 M(+37.2%) |
| Mar 2018 | - | $3.28 M(+64.8%) | $9.49 M(+25.3%) |
| Dec 2017 | $7.57 M(+94.7%) | $1.99 M(-26.1%) | $7.57 M(+35.7%) |
| Sep 2017 | - | $2.69 M(+76.2%) | $5.58 M(+93.2%) |
| Jun 2017 | - | $1.53 M(+12.2%) | $2.89 M(+112.2%) |
| Mar 2017 | - | $1.36 M | $1.36 M |
| Dec 2016 | $3.89 M | - | - |
FAQ
- What is Evelo Biosciences annual SGA?
- What is the all time high annual SGA for Evelo Biosciences?
- What is Evelo Biosciences annual SGA year-on-year change?
- What is Evelo Biosciences quarterly SGA?
- What is the all time high quarterly SGA for Evelo Biosciences?
- What is Evelo Biosciences quarterly SGA year-on-year change?
- What is Evelo Biosciences TTM SGA?
- What is the all time high TTM SGA for Evelo Biosciences?
- What is Evelo Biosciences TTM SGA year-on-year change?
What is Evelo Biosciences annual SGA?
The current annual SGA of EVLO is $29.91 M
What is the all time high annual SGA for Evelo Biosciences?
Evelo Biosciences all-time high annual SGA is $31.75 M
What is Evelo Biosciences annual SGA year-on-year change?
Over the past year, EVLO annual SGA has changed by -$1.84 M (-5.80%)
What is Evelo Biosciences quarterly SGA?
The current quarterly SGA of EVLO is $3.89 M
What is the all time high quarterly SGA for Evelo Biosciences?
Evelo Biosciences all-time high quarterly SGA is $10.11 M
What is Evelo Biosciences quarterly SGA year-on-year change?
Over the past year, EVLO quarterly SGA has changed by -$3.23 M (-45.40%)
What is Evelo Biosciences TTM SGA?
The current TTM SGA of EVLO is -$2.25 B
What is the all time high TTM SGA for Evelo Biosciences?
Evelo Biosciences all-time high TTM SGA is -$56.41 M
What is Evelo Biosciences TTM SGA year-on-year change?
Over the past year, EVLO TTM SGA has changed by -$2.28 B (-6791.52%)